BALLARD PARTNERS for APOTEX CORP.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 15, 2025 | $120,000 | Replaced |
| 1st Quarter - Amendment | Apr 19, 2025 | $120,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Manufacturing MAN
Advice and guidance related to supply chains and trade tariffs.
Foreign entity interest: Artemis Parent, Inc., Artemis Intermediate Holdings, Inc., and Apotex Holdco Inc., the parent companies of Apotex Corp., and Apotex Inc., its affiliate, identified on the LD-1 report, have direct or indirect interests in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BALLARD | — |
| HUNTER MORGEN | Policy Advisor, Office of Policy Planning, U.S. State Dept. (2017); Deputy Director, Office of Trade & Manufacturing Policy, WH (2017-2018); Special Assistant to the President, Office of the Senior Advisor for Policy, WH (2018-2020) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.